Search For "food and drug administration"
US formally recommends Pfizer COVID-19 vaccine for children aged 5-11
Updated : 4 years, 4 months ago IST
Washington [US], November 3 (ANI): Following rigorous review and authorization process by the US Food and Drug Administration (FDA), the Centers for Disease Control (CDC) on Tuesday (local time) has formally recommended the Pfizer COVID-19 vaccine for children 5-11.
Read More
FDA advisors to rule on Pfizer vaccine in younger children as experts fore
Updated : 4 years, 4 months ago IST
Washington [US], October 26 (ANI/Xinhua): Advisors to the U.S. Food and Drug Administration (FDA) are set for a key meeting Tuesday on whether to recommend the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, as experts predicted younger kids will be eligible for the vaccine in e
Read More
US-FDA's approval of mix and match COVID booster shots confirmation of eff
Updated : 4 years, 5 months ago IST
Moscow [Russia], October 21 (ANI): Following the decision by the US Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) reiterated that
Read More
FDA takes additional actions on use of booster dose for COVID-19 vaccines
Updated : 4 years, 5 months ago IST
Washington [US], October 21 (ANI): The US Food and Drug Administration (FDA) approved the use of third doses of the Moderna and Johnson and Johnson (Janssen) vaccines against the novel COVID-19 for eligible individuals.
Read More
US to allow entry to those fully vaccinated with WHO, FDA-approved shots
Updated : 4 years, 5 months ago IST
Washington [US], October 16 (ANI): The United States will allow entry only to those foreign nationals who have been fully immunised with a coronavirus vaccine that has been approved either by the Food and Drug Administration (FDA) or the World Health Organization (WHO), the State Department
Read More
Optimus receives tentative approval from U.S. FDA for Brexpiprazole Tablet
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], October 9 (ANI/PNN): Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti® Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 m
Read More
Covid antiviral pill cuts risk of hospitalisation, deaths by half, says ma
Updated : 4 years, 5 months ago IST
Washington [US], October 1 (ANI): An antiviral pill has been found to reduce the risk of hospitalisation and deaths by 50 per cent in patients diagnosed with COVID-19 during clinical trials.
Read More
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Amer
Updated : 4 years, 5 months ago IST
Washington [US], September 23 (ANI): US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk.
Read More
US FDA: No Pfizer booster shots for 16 and above, approved only for people
Updated : 4 years, 6 months ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 6 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Philippines approves Russia's Sputnik Light vaccine
Updated : 4 years, 6 months ago IST
Moscow [Russia], August 23 (ANI): The Philippines' Food and Drug Administration approved the single-component Sputnik Light coronavirus vaccine under the emergency use authorization procedure on Monday, the Russian Direct Investment Fund said.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 7 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More